Product Details for ANDA 083158
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
1%
Marketing Status: Prescription
2%
Marketing Status: Prescription
20%
Marketing Status: Discontinued
200MG/100ML
Marketing Status: Discontinued
400MG/100ML
Marketing Status: Discontinued
1%
Marketing Status: Prescription
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: A083158
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: A083158
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
2%
Marketing Status: Prescription
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: A083158
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: A083158
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
20%
Marketing Status: Discontinued
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083158
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083158
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
200MG/100ML
Marketing Status: Discontinued
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083158
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
Proprietary Name: LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083158
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
400MG/100ML
Marketing Status: Discontinued
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 400MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083158
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 400MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A083158
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information